Losing weight is such a slog. Will Wegovy be a silver bullet for China?
Danish pharmaceutical company Novo Nordisk announced last weekend that Wegovy, the weight-loss version of the company's high-profile, diabetes-control drug Ozempic, will soon officially hit the Chinese market.
Weight-loss drug Wegovy launched in China
Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.
Novo Nordisk launches obesity drug Wegovy in China
Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.
Popular weight-loss drug Wegovy goes on sale in China
Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It is set to intensify competition with rival Eli Lilly, whose popular weight-loss treatment also got the green light months ago but has yet to go on sale in the world's second largest pharmaceutical market.
Novo Nordisk Launches Wegovy in China With Prices Below US
Novo Nordisk A/S is launching its top-selling Wegovy obesity drug in China at a fraction of the US price, a key step in unlocking a big, fast-growing market for its blockbuster franchise.
Novo Nordisk's obesity drug Wegovy goes on sale in China
Novo Nordisk's blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday, as the Asian nation battles high rates of obesity.
Weight-Loss Drug Wegovy comes to China Amid Rising Demand
Novo Nordisk has officially launched its weight-loss drug Wegovy in China after receiving approval in June. The move pits it against rival Eli Lilly, whose treatment, Zepbound, is yet to hit shelves in the world's second-largest pharmaceutical market.
Novo Nordisk reportedly launches Wegovy in China
Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly (LLY). Read more here.
The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...
People on MSN11d
Mom Overdosed on Weight Loss Drug She Got on Instagram, Recalls 'Throwing Up Blood': 'Thought I Was Going to Die'
Leigh-Anne Lagden, 26, opened up about being hospitalized after accidentally overdosing on knockoff weight loss injections ...
Medicaid dominates coverage of Novo, Lilly weight-loss drugs
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...
Insurancenewsnet.com1h
Insurers face tough risk call on weight loss drugs like Ozempic, says panel
In 2021, the agency added Wegovy, a version approved for weight loss treatment, without obliging insurance companies to cover it. Both are made by Novo Nordisk, a Danish company. The drugmaker ...
tyla7d
Company behind weight loss drug Mounjaro issues statement as first Brit dies after using jab twice
Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...
Eli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free
Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...